Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Oosting, Sjoukje F van der Veldt, Astrid A M Fehrmann, Rudolf S N GeurtsvanKessel, Corine H van Binnendijk, Rob S Dingemans, Anne-Marie C Smit, Egbert F Hiltermann, T Jeroen N den Hartog, Gerco Jalving, Mathilda
Oosting, Sjoukje F
van der Veldt, Astrid A M
Fehrmann, Rudolf S N
GeurtsvanKessel, Corine H
van Binnendijk, Rob S
Dingemans, Anne-Marie C
Smit, Egbert F
Hiltermann, T Jeroen N
den Hartog, Gerco
Jalving, Mathilda
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2022-04-25
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Translated Title
Published in
The Lancet. Oncology 2022; 23(7):833-835